Article info
PDFLaboratory science
Higher aqueous levels of matrix metalloproteinases indicated visual impairment in patients with retina vein occlusion after anti-VEGF therapy
- Correspondence to Dr Zhongping Chen, AIER Eye Hospital of Changsha, Aier Eye Hospital Group, Changsha, China; chenzhongping{at}aierchina.com; Dr Heping Xu; Heping.xu{at}qub.ac.uk
Citation
Higher aqueous levels of matrix metalloproteinases indicated visual impairment in patients with retina vein occlusion after anti-VEGF therapy
Publication history
- Received October 8, 2019
- Revised November 26, 2019
- Accepted November 30, 2019
- First published December 16, 2019.
Online issue publication
June 23, 2021
Article Versions
- Previous version (23 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.